Boosting R&D Productivity
The pathway to a development candidate is rarely straight and smooth. A recent McKinsey article detailed some of the challenges faced by R&D organisations in biotech and pharmaceutical companies in that journey, and some of the initiatives being undertaken across the industry.
Industry reports like these tend to focus heavily on the "D" and not really the "R" when describing the ways in which companies can improve productivity. To be fair, the development end of the business tends to be more public, and therefore gets more scrutiny. Nevertheless there were some interesting takeaways from the article, which I invite you to read here.
What was perhaps most compelling about the article were 4 key characteristics of the High-performance R&D delivery engine (outlined in red) and the initiatives that the industry is undertaking in those areas to improve performance. Since the article has a more development-oriented slant to it, we've taken a more discovery-oriented slant in this article and provided some examples that show how our Pipeline platform can be used to support those initiatives.
Simplified, Automated, and Digitised Core Processes
Simplified, automated, and digitized core processes can boost R&D productivity by:
Some specific examples of how simplified, automated, and digitized core processes can boost R&D productivity include:
By simplifying, automating, and digitizing core processes, R&D organizations can improve productivity, reduce costs, and accelerate the development of new drugs and therapies.
Pipeline’s workflow-oriented modules make it possible for research teams to create and manage workflows and receive real-time notifications as things change. Each step in the workflow supports threaded communication making collaboration easier and less siloed. Pipeline’s Inventory module is integrated into Protein Production and Chemistry workflows, making it possible to register proteins (and other biologics) and compounds and place them into inventory from within the workflow itself. The scientist never has to leave their current workflow in order to manage their inventory.
Pipeline’s Field Library allows scientists to use industry standard vocabularies when recording and sharing data, thereby improving data quality and consistency both within the organisation and when working with CROs and service partners.
We’re also seeing biotech companies hit certain inflection points where it becomes more cost-effective and efficient to bring automated compound synthesis in-house. Here it’s essential to be able to plug-in support for different liquid handlers, and weighing robots in a manner that lets these systems decompose a high-level compound library request into a series of automated requests for building blocks, reaction protocols, liquid dispensing operations, etc.
Enabling the R&D System to Boost Productivity
In addition to simplifying, automating, and digitizing core processes, R&D organizations can also boost productivity by enabling the R&D system. This includes making improvements in decision-making, footprint, and organization.
Decision-Making
Footprint
领英推荐
Organization
By enabling the R&D system, organizations can create an environment that is conducive to innovation and productivity. This will help to accelerate the development of new drugs and therapies, and improve the lives of patients.
Pipeline’s Planning module allows scientists to create goals for drug discovery projects and to align their activities with those goals. The Target Product Profile helps the team focus on a Minimum Viable Product (MVP). The GRIDALL implementation helps the team devolve a high-level set of Goals into a set of identified Risks, Issues, Decisions, Actions and Lessons Learned and allow the team to chart a clear course to that MVP.
Pipeline’s Field Library and Workflow Builder allows users to customise their workflows and gather critical information needed to facilitate data-driven decision making.
Pipeline’s notifications, activity feed, and communication threads help improve communication, collaboration and real-time awareness of project and activity status. It makes more of the work of drug discovery transparent at every level of your organisation from the lab to the leadership team.
Next-generation Data, Analytics, and Technology
Next-generation data, analytics, and technology can improve R&D productivity in a number of ways:
By leveraging next-generation data, analytics, and technology, R&D organizations can improve productivity, reduce costs, and accelerate the development of new drugs and therapies.
Informatics environments tend to consist of applications that generate disconnected islands of data. Pipeline’s plugin-oriented architecture allows companies to leverage the investments that they’ve already made in ELNs, registration systems and inventory management systems and integrate these systems and their data together. The Field Library allows the user to map data from one system to another, and in the process map the data to a standard ontology, thus helping to ensure data consistency.
The initial hurdle that all AI/ML initiatives face is data standardisation. We have to have clean, consistent data sets in order to create accurate models. The challenge here is that each system may refer to a given field of data differently. Pipeline’s Field Library provides that consistency across the system that is essential for any AI/ML implementation. Moreover, the built-in Calculation Engine allows scientists to apply AI/ML models to data in the system.
Streamlined Vendor Partnerships
Streamlined vendor partnerships can improve R&D productivity in a number of ways:
Overall, streamlined vendor partnerships can play a vital role in improving R&D productivity. By leveraging the expertise, resources, and capabilities of vendors, R&D organizations can accelerate the development process, reduce costs, and improve the quality of their research.
Pipeline’s PharmExchange service makes it possible for researchers to create workflows capable of requesting services from CROs and service providers, exchanging data with them and tracking the progress of those requests in real-time. Many of these collaborations will fail because of a breakdown in trust. To mitigate this risk, it's essential for biotech companies and CROs to share not only basic metadata about an assay (for example descriptions of the fields of data being exchanged), but also protocol information about the assay that describe how those data were generated or computed.?
Combined with the Planning module, scientists can estimate the costs involved with executing certain workflows where selected steps are performed by CROs. The Planning module can help scientists estimate compound and protein requirements for screening cascades.
If you'd like to learn more about Pipeline and how it can transform your R&D organisation contact me Mark Fortner
Senior Sales Account Manager in Business Development, specializing in North American markets for Cellular Therapies in Drug Discovery.
2 个月You pulled me in with the impressive wave shot ?? and I enjoy the simplification of visuality here and in the article. Automation apparently is the key.